Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069758
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2003-09-30
Brief Title:
Safety and Activity of SDX-105 Bendamustine in Patients With Rituximab Refractory Non-Hodgkins Lymphoma
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04
Completion Date Type:
ACTUAL
First Submit Date:
2003-09-30
First Submit QC Date:
October 1 2003
Study First Post Date:
2003-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-08
Last Update Post Date:
2014-05-09
Last Update Post Date Type:
ESTIMATED